<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-10-17" modified="2020-08-12" version="161">
<accession>Q5VWQ8</accession>
<accession>A6H8V2</accession>
<accession>A6NHI9</accession>
<accession>B0QZB1</accession>
<accession>G3XA90</accession>
<accession>Q8TDL2</accession>
<accession>Q96SE1</accession>
<accession>Q9C0C0</accession>
<name>DAB2P_HUMAN</name>
<protein>
<recommendedName>
<fullName>Disabled homolog 2-interacting protein</fullName>
<shortName>DAB2 interaction protein</shortName>
<shortName>DAB2-interacting protein</shortName>
</recommendedName>
<alternativeName>
<fullName>ASK-interacting protein 1</fullName>
<shortName>AIP-1</shortName>
</alternativeName>
<alternativeName>
<fullName>DOC-2/DAB-2 interactive protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">DAB2IP</name>
<name type="synonym">AF9Q34</name>
<name type="synonym">AIP1</name>
<name type="synonym">KIAA1743</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="Genomics" volume="79" first="573" last="581">
<title>Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.</title>
<authorList>
<person name="Chen H."/>
<person name="Pong R.-C."/>
<person name="Wang Z."/>
<person name="Hsieh J.-T."/>
</authorList>
<dbReference type="PubMed" id="11944990"/>
<dbReference type="DOI" id="10.1006/geno.2002.6739"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genes Chromosomes Cancer" volume="39" first="324" last="334">
<title>Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.</title>
<authorList>
<person name="von Bergh A.R.M."/>
<person name="Wijers P.M."/>
<person name="Groot A.J."/>
<person name="van Zelderen-Bhola S."/>
<person name="Falkenburg J.H.F."/>
<person name="Kluin P.M."/>
<person name="Schuuring E."/>
</authorList>
<dbReference type="PubMed" id="14978793"/>
<dbReference type="DOI" id="10.1002/gcc.20004"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH KMT2A/MLL1</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="DNA Res." volume="7" first="347" last="355">
<title>Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Hattori A."/>
<person name="Kondo Y."/>
<person name="Okumura K."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="11214970"/>
<dbReference type="DOI" id="10.1093/dnares/7.6.347"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Clin. Invest." volume="111" first="1933" last="1943">
<title>AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3.</title>
<authorList>
<person name="Zhang R."/>
<person name="He X."/>
<person name="Liu W."/>
<person name="Lu M."/>
<person name="Hsieh J.-T."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="12813029"/>
<dbReference type="DOI" id="10.1172/jci200317790"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP3K5</scope>
<scope>MUTAGENESIS OF 228-LYS--LYS-230; 281-LYS--LYS-284 AND ARG-413</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="44955" last="44965">
<title>AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.</title>
<authorList>
<person name="Zhang H."/>
<person name="Zhang R."/>
<person name="Luo Y."/>
<person name="D'Alessio A."/>
<person name="Pober J.S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="15310755"/>
<dbReference type="DOI" id="10.1074/jbc.m407617200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TNFR1; MAP3K5; TRADD; RALBP1 AND TRAF2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="15061" last="15070">
<title>Tumor necrosis factor alpha-induced desumoylation and cytoplasmic translocation of homeodomain-interacting protein kinase 1 are critical for apoptosis signal-regulating kinase 1-JNK/p38 activation.</title>
<authorList>
<person name="Li X."/>
<person name="Zhang R."/>
<person name="Luo D."/>
<person name="Park S.-J."/>
<person name="Wang Q."/>
<person name="Kim Y."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="15701637"/>
<dbReference type="DOI" id="10.1074/jbc.m414262200"/>
</citation>
<scope>INTERACTION WITH HIPK1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="14788" last="14796">
<title>RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.</title>
<authorList>
<person name="Zhang H."/>
<person name="Zhang H."/>
<person name="Lin Y."/>
<person name="Li J."/>
<person name="Pober J.S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="17389591"/>
<dbReference type="DOI" id="10.1074/jbc.m701148200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH 14-3-3 PROTEINS; MAP3K5; RIPK1 AND TRAF2</scope>
<scope>PHOSPHORYLATION AT SER-728</scope>
<scope>MUTAGENESIS OF SER-728 AND THR-935</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Circ. Res." volume="102" first="840" last="848">
<title>AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation.</title>
<authorList>
<person name="Min W."/>
<person name="Lin Y."/>
<person name="Tang S."/>
<person name="Yu L."/>
<person name="Zhang H."/>
<person name="Wan T."/>
<person name="Luhn T."/>
<person name="Fu H."/>
<person name="Chen H."/>
</authorList>
<dbReference type="PubMed" id="18292600"/>
<dbReference type="DOI" id="10.1161/circresaha.107.168153"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-728</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Clin. Invest." volume="118" first="3904" last="3916">
<title>AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice.</title>
<authorList>
<person name="Zhang H."/>
<person name="He Y."/>
<person name="Dai S."/>
<person name="Xu Z."/>
<person name="Luo Y."/>
<person name="Wan T."/>
<person name="Luo D."/>
<person name="Jones D."/>
<person name="Tang S."/>
<person name="Chen H."/>
<person name="Sessa W.C."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="19033661"/>
<dbReference type="DOI" id="10.1172/jci36168"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KDR AND P85 SUBUNIT OF PI3K</scope>
<scope>MUTAGENESIS OF 228-LYS--LYS-230 AND 281-LYS--LYS-284</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="19878" last="19883">
<title>DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.</title>
<authorList>
<person name="Xie D."/>
<person name="Gore C."/>
<person name="Zhou J."/>
<person name="Pong R.C."/>
<person name="Zhang H."/>
<person name="Yu L."/>
<person name="Vessella R.L."/>
<person name="Min W."/>
<person name="Hsieh J.T."/>
</authorList>
<dbReference type="PubMed" id="19903888"/>
<dbReference type="DOI" id="10.1073/pnas.0908458106"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AKT1 AND P85 SUBUNIT OF PI3K</scope>
<scope>PHOSPHORYLATION AT SER-728</scope>
<scope>MUTAGENESIS OF ARG-413; SER-728 AND 920-PRO--PRO-929</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3750" last="3757">
<title>AIP1 functions as Arf6-GAP to negatively regulate TLR4 signaling.</title>
<authorList>
<person name="Wan T."/>
<person name="Liu T."/>
<person name="Zhang H."/>
<person name="Tang S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="19948740"/>
<dbReference type="DOI" id="10.1074/jbc.m109.069385"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PHOSPHATIDYLINOSITOL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ARG-413</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="286" last="294">
<title>An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB.</title>
<authorList>
<person name="Min J."/>
<person name="Zaslavsky A."/>
<person name="Fedele G."/>
<person name="McLaughlin S.K."/>
<person name="Reczek E.E."/>
<person name="De Raedt T."/>
<person name="Guney I."/>
<person name="Strochlic D.E."/>
<person name="Macconaill L.E."/>
<person name="Beroukhim R."/>
<person name="Bronson R.T."/>
<person name="Ryeom S."/>
<person name="Hahn W.C."/>
<person name="Loda M."/>
<person name="Cichowski K."/>
</authorList>
<dbReference type="PubMed" id="20154697"/>
<dbReference type="DOI" id="10.1038/nm.2100"/>
</citation>
<scope>FUNCTION IN PROSTATE CANCER</scope>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF ARG-413 AND SER-728</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="2485" last="2490">
<title>Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.</title>
<authorList>
<person name="Xie D."/>
<person name="Gore C."/>
<person name="Liu J."/>
<person name="Pong R.C."/>
<person name="Mason R."/>
<person name="Hao G."/>
<person name="Long M."/>
<person name="Kabbani W."/>
<person name="Yu L."/>
<person name="Zhang H."/>
<person name="Chen H."/>
<person name="Sun X."/>
<person name="Boothman D.A."/>
<person name="Min W."/>
<person name="Hsieh J.T."/>
</authorList>
<dbReference type="PubMed" id="20080667"/>
<dbReference type="DOI" id="10.1073/pnas.0908133107"/>
</citation>
<scope>FUNCTION IN PROSTATE CANCER</scope>
<scope>INTERACTION WITH GSK3B AND PPP2CA</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Circ. Res." volume="109" first="418" last="427">
<title>AIP1 prevents graft arteriosclerosis by inhibiting interferon-gamma-dependent smooth muscle cell proliferation and intimal expansion.</title>
<authorList>
<person name="Yu L."/>
<person name="Qin L."/>
<person name="Zhang H."/>
<person name="He Y."/>
<person name="Chen H."/>
<person name="Pober J.S."/>
<person name="Tellides G."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="21700930"/>
<dbReference type="DOI" id="10.1161/circresaha.111.248245"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH JAK2</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-978</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Clin. Cancer Res." volume="18" first="4048" last="4058">
<title>EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.</title>
<authorList>
<person name="Smits M."/>
<person name="van Rijn S."/>
<person name="Hulleman E."/>
<person name="Biesmans D."/>
<person name="van Vuurden D.G."/>
<person name="Kool M."/>
<person name="Haberler C."/>
<person name="Aronica E."/>
<person name="Vandertop W.P."/>
<person name="Noske D.P."/>
<person name="Wurdinger T."/>
</authorList>
<dbReference type="PubMed" id="22696229"/>
<dbReference type="DOI" id="10.1158/1078-0432.ccr-12-0399"/>
</citation>
<scope>FUNCTION IN MEDULLOBLASTOMA DEVELOPMENT</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-747; SER-978 AND SER-995</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<comment type="function">
<text evidence="9 13 14 15 16 17 18 19 20 21">Functions as a scaffold protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Involved in several processes such as innate immune response, inflammation and cell growth inhibition, apoptosis, cell survival, angiogenesis, cell migration and maturation. Plays also a role in cell cycle checkpoint control; reduces G1 phase cyclin levels resulting in G0/G1 cell cycle arrest. Mediates signal transduction by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF), interferon (IFN) or lipopolysaccharide (LPS). Modulates the balance between phosphatidylinositol 3-kinase (PI3K)-AKT-mediated cell survival and apoptosis stimulated kinase (MAP3K5)-JNK signaling pathways; sequesters both AKT1 and MAP3K5 and counterbalances the activity of each kinase by modulating their phosphorylation status in response to proinflammatory stimuli. Acts as a regulator of the endoplasmic reticulum (ER) unfolded protein response (UPR) pathway; specifically involved in transduction of the ER stress-response to the JNK cascade through ERN1. Mediates TNF-alpha-induced apoptosis activation by facilitating dissociation of inhibitor 14-3-3 from MAP3K5; recruits the PP2A phosphatase complex which dephosphorylates MAP3K5 on 'Ser-966', leading to the dissociation of 13-3-3 proteins and activation of the MAP3K5-JNK signaling pathway in endothelial cells. Mediates also TNF/TRAF2-induced MAP3K5-JNK activation, while it inhibits CHUK-NF-kappa-B signaling. Acts a negative regulator in the IFN-gamma-mediated JAK-STAT signaling cascade by inhibiting smooth muscle cell (VSMCs) proliferation and intimal expansion, and thus, prevents graft arteriosclerosis (GA). Acts as a GTPase-activating protein (GAP) for the ADP ribosylation factor 6 (ARF6) and Ras. Promotes hydrolysis of the ARF6-bound GTP and thus, negatively regulates phosphatidylinositol 4,5-bisphosphate (PIP2)-dependent TLR4-TIRAP-MyD88 and NF-kappa-B signaling pathways in endothelial cells in response to lipopolysaccharides (LPS). Binds specifically to phosphatidylinositol 4-phosphate (PtdIns4P) and phosphatidylinositol 3-phosphate (PtdIns3P). In response to vascular endothelial growth factor (VEGFA), acts as a negative regulator of the VEGFR2-PI3K-mediated angiogenic signaling pathway by inhibiting endothelial cell migration and tube formation. In the developing brain, promotes both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex in a glial-dependent locomotion process. Probable downstream effector of the Reelin signaling pathway; promotes Purkinje cell (PC) dendrites development and formation of cerebellar synapses. Functions also as a tumor suppressor protein in prostate cancer progression; prevents cell proliferation and epithelial-to-mesenchymal transition (EMT) through activation of the glycogen synthase kinase-3 beta (GSK3B)-induced beta-catenin and inhibition of PI3K-AKT and Ras-MAPK survival downstream signaling cascades, respectively.</text>
</comment>
<comment type="subunit">
<text evidence="3 9 11 12 13 15 16 17 18 20">On plasma membrane, exists in an inactive form complexed with TNFR1; in response to TNF-alpha, dissociates from TNFR1 complex, translocates to cytoplasm and forms part of an intracellular signaling complex comprising TRADD, RALBP1, TRAF2 and MAP3K5. Interacts with DAB1. Interacts (via NPXY motif) with DAB2 (via PID domain). Interacts (via PH domain) with ERN1 (By similarity). Part of a cytoplasmic complex made of HIPK1, DAB2IP and MAP3K5 in response to TNF-alpha; this complex formation promotes MAP3K5-JNK activation and subsequent apoptosis. Interacts (via N-terminal domain) with JAK2; the interaction occurs in a IFNG/IFN-gamma-dependent manner and inhibits JAK2 autophosphorylation activity. Interacts (via C2 domain) with GSK3B; the interaction stimulates GSK3B kinase activation. Interacts (via C2 domain) with PPP2CA. Interacts (via proline-rich motif) with a regulatory p85 subunit (via SH3 domain) of the PI3K complex; the interaction inhibits the PI3K-AKT complex activity in a TNF-alpha-dependent manner in prostate cancer (PCa) cells. Interacts with AKT1; the interaction is increased in a TNF-alpha-induced manner. Interacts (via C2 domain and active form preferentially) with KDR/VEGFR2 (tyrosine-phosphorylated active form preferentially); the interaction occurs at the late phase of VEGFA response and inhibits KDR/VEGFR2 activity. Interacts (via N-terminus C2 domain) with MAP3K5 ('Ser-966' dephosphorylated form preferentially); the interaction occurs in a TNF-alpha-induced manner. Interacts (via Ras-GAP domain) with the catalytic subunit of protein phosphatase PP2A; the interaction occurs in resting endothelial cells, is further enhanced by TNF-alpha stimulation and is required to bridge PP2A to MAP3K5. Interacts (via C-terminus PER domain) with TRAF2 (via zinc fingers); the interaction occurs in a TNF-alpha-dependent manner. Interacts with 14-3-3 proteins; the interaction occurs in a TNF-alpha-dependent manner. Interacts (via Ras-GAP domain) with RIPK1 (via kinase domain); the interaction occurs in a TNF-alpha-dependent manner.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2871881">
<id>Q5VWQ8</id>
</interactant>
<interactant intactId="EBI-2871881">
<id>Q5VWQ8</id>
<label>DAB2IP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2871881">
<id>Q5VWQ8</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2871881">
<id>Q5VWQ8</id>
</interactant>
<interactant intactId="EBI-476263">
<id>Q99683</id>
<label>MAP3K5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9543020">
<id>Q5VWQ8-2</id>
</interactant>
<interactant intactId="EBI-710484">
<id>O15169</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9543020">
<id>Q5VWQ8-2</id>
</interactant>
<interactant intactId="EBI-373586">
<id>P49841</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-12196395">
<id>Q5VWQ8-5</id>
</interactant>
<interactant intactId="EBI-11954519">
<id>Q49AR9</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Cell membrane</location>
<topology evidence="26">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cell projection</location>
<location evidence="3">Dendrite</location>
</subcellularLocation>
<text evidence="3">Localized in soma and dendrites of Purkinje cells as well as in scattered cell bodies in the molecular layer of the cerebellum (By similarity). Colocalizes with TIRAP at the plasma membrane. Colocalizes with ARF6 at the plasma membrane and endocytic vesicles. Translocates from the plasma membrane to the cytoplasm in response to TNF-alpha. Phosphatidylinositol 4-phosphate (PtdIns4P) binding is essential for plasma membrane localization.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q5VWQ8-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q5VWQ8-2</id>
<name>2</name>
<sequence type="described" ref="VSP_020953"/>
</isoform>
<isoform>
<id>Q5VWQ8-3</id>
<name>3</name>
<sequence type="described" ref="VSP_020952 VSP_020954"/>
</isoform>
<isoform>
<id>Q5VWQ8-4</id>
<name>4</name>
<sequence type="described" ref="VSP_020953 VSP_020954"/>
</isoform>
<isoform>
<id>Q5VWQ8-5</id>
<name>5</name>
<sequence type="described" ref="VSP_047361 VSP_020954"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 13 20 21">Expressed in endothelial and vascular smooth muscle cells (VSMCs). Expressed in prostate epithelial but poorly in prostate cancer cells. Poorly expressed in medulloblastoma cells compared to cerebellar precursor proliferating progenitor cells (at protein level). Low expression in prostate. Down-regulated in prostate cancer.</text>
</comment>
<comment type="induction">
<text evidence="19 21">Down-regulated in prostate cancer and medulloblastoma.</text>
</comment>
<comment type="domain">
<text evidence="3">The C2 and Ras-GAP domains constitutively bind to MAP3K5 and facilitate the release of 14-3-3 proteins from MAP3K5. The PH and Ras-GAP domains, but not the NPXY motif, are crucial for its cell membrane localization and neuronal migration function. The PH domain is necessary but not sufficient to activate the JNK signaling pathway through ERN1 (By similarity). Exists in a closed inactive form by an intramolecular interaction between the N- and the C-terminal domains. The proline-rich motif is critical both for PI3K-AKT activity inhibition and MAP3K5 activation. The PH and C2 domains are necessary for the binding to phosphatidylinositol phosphate. The Ras-GAP domain is necessary for its tumor-suppressive function.</text>
</comment>
<comment type="PTM">
<text evidence="13 16">In response to TNF-alpha-induction, phosphorylated at Ser-728; phosphorylation leads to a conformational change, and thus, increases its association with 14-3-3 proteins, MAP3K5, RIPK1 and TRAF2 in endothelial cells; also stimulates regulatory p85 subunit sequestring and PI3K-p85 complex activity inhibition.</text>
</comment>
<comment type="disease">
<text evidence="10">A chromosomal aberration involving DAB2IP is found in a patient with acute myeloid leukemia (AML). Translocation t(9;11)(q34;q23) with KMT2A/MLL1. May give rise to a KMT2A/MLL1-DAB2IP fusion protein lacking the PH domain (PubMed:14978793).</text>
</comment>
<comment type="miscellaneous">
<text evidence="27 28">The DAB2IP gene is found epigenetically silenced in numerous aggressive cancers, like prostate cancers and medulloblastoma tumors. Epigenetic suppression of DAB2IP by EZH2 is a major mechanism of DAB2IP inactivation in human prostate cancer and increases metastatic potential (PubMed:20154697, PubMed:22696229).</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/AF9q34ID316.html"/>
</comment>
<dbReference type="EMBL" id="AF367051">
<property type="protein sequence ID" value="AAM00371.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY032952">
<property type="protein sequence ID" value="AAK50336.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB051530">
<property type="protein sequence ID" value="BAB21834.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL357936">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL365274">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87503.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471090">
<property type="protein sequence ID" value="EAW87504.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC146762">
<property type="protein sequence ID" value="AAI46763.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6832.1">
<molecule id="Q5VWQ8-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6833.2">
<molecule id="Q5VWQ8-5"/>
</dbReference>
<dbReference type="RefSeq" id="NP_115941.2">
<molecule id="Q5VWQ8-5"/>
<property type="nucleotide sequence ID" value="NM_032552.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_619723.1">
<molecule id="Q5VWQ8-2"/>
<property type="nucleotide sequence ID" value="NM_138709.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005251776.1">
<molecule id="Q5VWQ8-1"/>
<property type="nucleotide sequence ID" value="XM_005251719.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516572.1">
<molecule id="Q5VWQ8-2"/>
<property type="nucleotide sequence ID" value="XM_011518270.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011516573.1">
<molecule id="Q5VWQ8-2"/>
<property type="nucleotide sequence ID" value="XM_011518271.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869789.1">
<molecule id="Q5VWQ8-2"/>
<property type="nucleotide sequence ID" value="XM_017014300.1"/>
</dbReference>
<dbReference type="SMR" id="Q5VWQ8"/>
<dbReference type="BioGRID" id="127478">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="DIP" id="DIP-41721N"/>
<dbReference type="IntAct" id="Q5VWQ8">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000259371"/>
<dbReference type="CarbonylDB" id="Q5VWQ8"/>
<dbReference type="iPTMnet" id="Q5VWQ8"/>
<dbReference type="PhosphoSitePlus" id="Q5VWQ8"/>
<dbReference type="BioMuta" id="DAB2IP"/>
<dbReference type="DMDM" id="116247768"/>
<dbReference type="EPD" id="Q5VWQ8"/>
<dbReference type="jPOST" id="Q5VWQ8"/>
<dbReference type="MassIVE" id="Q5VWQ8"/>
<dbReference type="MaxQB" id="Q5VWQ8"/>
<dbReference type="PaxDb" id="Q5VWQ8"/>
<dbReference type="PeptideAtlas" id="Q5VWQ8"/>
<dbReference type="PRIDE" id="Q5VWQ8"/>
<dbReference type="ProteomicsDB" id="33682"/>
<dbReference type="ProteomicsDB" id="65554">
<molecule id="Q5VWQ8-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="65555">
<molecule id="Q5VWQ8-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="65556">
<molecule id="Q5VWQ8-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="65557">
<molecule id="Q5VWQ8-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="48362">
<property type="antibodies" value="96 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000259371">
<molecule id="Q5VWQ8-5"/>
<property type="protein sequence ID" value="ENSP00000259371"/>
<property type="gene ID" value="ENSG00000136848"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000309989">
<molecule id="Q5VWQ8-2"/>
<property type="protein sequence ID" value="ENSP00000310827"/>
<property type="gene ID" value="ENSG00000136848"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000408936">
<molecule id="Q5VWQ8-1"/>
<property type="protein sequence ID" value="ENSP00000386183"/>
<property type="gene ID" value="ENSG00000136848"/>
</dbReference>
<dbReference type="GeneID" id="153090"/>
<dbReference type="KEGG" id="hsa:153090"/>
<dbReference type="UCSC" id="uc004bln.5">
<molecule id="Q5VWQ8-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="153090"/>
<dbReference type="DisGeNET" id="153090"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136848.16"/>
<dbReference type="GeneCards" id="DAB2IP"/>
<dbReference type="HGNC" id="HGNC:17294">
<property type="gene designation" value="DAB2IP"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136848">
<property type="expression patterns" value="Tissue enhanced (brain)"/>
</dbReference>
<dbReference type="MIM" id="609205">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q5VWQ8"/>
<dbReference type="OpenTargets" id="ENSG00000136848"/>
<dbReference type="PharmGKB" id="PA27133"/>
<dbReference type="eggNOG" id="KOG3508">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155853"/>
<dbReference type="HOGENOM" id="CLU_001727_1_0_1"/>
<dbReference type="InParanoid" id="Q5VWQ8"/>
<dbReference type="KO" id="K19901"/>
<dbReference type="OMA" id="PMTRGRT"/>
<dbReference type="OrthoDB" id="69536at2759"/>
<dbReference type="PhylomeDB" id="Q5VWQ8"/>
<dbReference type="TreeFam" id="TF105303"/>
<dbReference type="PathwayCommons" id="Q5VWQ8"/>
<dbReference type="Reactome" id="R-HSA-5658442">
<property type="pathway name" value="Regulation of RAS by GAPs"/>
</dbReference>
<dbReference type="SIGNOR" id="Q5VWQ8"/>
<dbReference type="BioGRID-ORCS" id="153090">
<property type="hits" value="3 hits in 867 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="DAB2IP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="DAB2IP"/>
<dbReference type="GenomeRNAi" id="153090"/>
<dbReference type="Pharos" id="Q5VWQ8">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q5VWQ8"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="Q5VWQ8">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136848">
<property type="expression patterns" value="Expressed in cerebellum and 204 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q5VWQ8">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q5VWQ8">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:1990597">
<property type="term" value="C:AIP1-IRE1 complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044300">
<property type="term" value="C:cerebellar mossy fiber"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044301">
<property type="term" value="C:climbing fiber"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032809">
<property type="term" value="C:neuronal cell body membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990032">
<property type="term" value="C:parallel fiber"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071889">
<property type="term" value="F:14-3-3 protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005123">
<property type="term" value="F:death receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005096">
<property type="term" value="F:GTPase activator activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031435">
<property type="term" value="F:mitogen-activated protein kinase kinase kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043548">
<property type="term" value="F:phosphatidylinositol 3-kinase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036312">
<property type="term" value="F:phosphatidylinositol 3-kinase regulatory subunit binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032266">
<property type="term" value="F:phosphatidylinositol-3-phosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070273">
<property type="term" value="F:phosphatidylinositol-4-phosphate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035591">
<property type="term" value="F:signaling adaptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043184">
<property type="term" value="F:vascular endothelial growth factor receptor 2 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007257">
<property type="term" value="P:activation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000185">
<property type="term" value="P:activation of MAPKKK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0021814">
<property type="term" value="P:cell motility involved in cerebral cortex radial glia guided migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034620">
<property type="term" value="P:cellular response to unfolded protein"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035924">
<property type="term" value="P:cellular response to vascular endothelial growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072577">
<property type="term" value="P:endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008625">
<property type="term" value="P:extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070059">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0021819">
<property type="term" value="P:layer formation in cerebral cortex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903363">
<property type="term" value="P:negative regulation of cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010596">
<property type="term" value="P:negative regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042059">
<property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010633">
<property type="term" value="P:negative regulation of epithelial cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050680">
<property type="term" value="P:negative regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010719">
<property type="term" value="P:negative regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070373">
<property type="term" value="P:negative regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034260">
<property type="term" value="P:negative regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043553">
<property type="term" value="P:negative regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014067">
<property type="term" value="P:negative regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071901">
<property type="term" value="P:negative regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046580">
<property type="term" value="P:negative regulation of Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034144">
<property type="term" value="P:negative regulation of toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030948">
<property type="term" value="P:negative regulation of vascular endothelial growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900747">
<property type="term" value="P:negative regulation of vascular endothelial growth factor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048812">
<property type="term" value="P:neuron projection morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001235">
<property type="term" value="P:positive regulation of apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071158">
<property type="term" value="P:positive regulation of cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900006">
<property type="term" value="P:positive regulation of dendrite development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903896">
<property type="term" value="P:positive regulation of IRE1-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043507">
<property type="term" value="P:positive regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001224">
<property type="term" value="P:positive regulation of neuron migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901800">
<property type="term" value="P:positive regulation of proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031334">
<property type="term" value="P:positive regulation of protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090129">
<property type="term" value="P:positive regulation of synapse maturation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038026">
<property type="term" value="P:reelin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0040008">
<property type="term" value="P:regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043087">
<property type="term" value="P:regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043122">
<property type="term" value="P:regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900744">
<property type="term" value="P:regulation of p38MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043254">
<property type="term" value="P:regulation of protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035148">
<property type="term" value="P:tube formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036324">
<property type="term" value="P:vascular endothelial growth factor receptor-2 signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR030403">
<property type="entry name" value="DAB2IP"/>
</dbReference>
<dbReference type="InterPro" id="IPR021887">
<property type="entry name" value="DUF3498"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR039360">
<property type="entry name" value="Ras_GTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR023152">
<property type="entry name" value="RasGAP_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001936">
<property type="entry name" value="RasGAP_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008936">
<property type="entry name" value="Rho_GTPase_activation_prot"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10194">
<property type="entry name" value="PTHR10194"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10194:SF26">
<property type="entry name" value="PTHR10194:SF26"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12004">
<property type="entry name" value="DUF3498"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00616">
<property type="entry name" value="RasGAP"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00323">
<property type="entry name" value="RasGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48350">
<property type="entry name" value="SSF48350"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00509">
<property type="entry name" value="RAS_GTPASE_ACTIV_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50018">
<property type="entry name" value="RAS_GTPASE_ACTIV_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-0343">GTPase activation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0834">Unfolded protein response</keyword>
<feature type="chain" description="Disabled homolog 2-interacting protein" id="PRO_0000252407">
<location>
<begin position="1"/>
<end position="1189"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="6">
<location>
<begin position="101"/>
<end position="202"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="5">
<location>
<begin position="193"/>
<end position="311"/>
</location>
</feature>
<feature type="domain" description="Ras-GAP" evidence="7">
<location>
<begin position="371"/>
<end position="563"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with AKT1" evidence="16">
<location>
<begin position="646"/>
<end position="943"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="4">
<location>
<begin position="1026"/>
<end position="1159"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg-rich">
<location>
<begin position="8"/>
<end position="52"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="112"/>
<end position="117"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="867"/>
<end position="870"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="903"/>
<end position="948"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KMT2A/MLL1-DAB2IP">
<location>
<begin position="172"/>
<end position="173"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K5 and RIPK1" evidence="13 16">
<location>
<position position="728"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="747"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2">
<location>
<position position="978"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="995"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_020952" evidence="23">
<location>
<begin position="1"/>
<end position="193"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_020953" evidence="22 24 25">
<location>
<begin position="1"/>
<end position="124"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_047361" evidence="26">
<original>SAGGSARKSTGRSSYYYRLLRRPRLQRQRSRSRSRTRPAR</original>
<variation>EPDSLLDQDDSY</variation>
<location>
<begin position="2"/>
<end position="41"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4 and isoform 5." id="VSP_020954" evidence="22 23 25">
<original>RYSMQARNGISPTNPTKLQITENGEFRNSSNC</original>
<variation>SMH</variation>
<location>
<begin position="1158"/>
<end position="1189"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7027492." id="VAR_056858">
<original>S</original>
<variation>F</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with KDR/VEGFR2. Does not inhibit interaction with MAP3K5." evidence="9 15">
<original>KKK</original>
<variation>AAA</variation>
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significantly reduces interaction with MAP3K5. Does not reduce interaction with KDR/VEGFR2." evidence="9 15">
<original>KKKK</original>
<variation>AAAA</variation>
<location>
<begin position="281"/>
<end position="284"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit interaction with MAP3K5. Does not reduce GSK3B-induced beta-catenin transcription activity, TNF-alpha-induced apoptosis, ARF6-mediated TLR4-TIRAP-MyD88 signaling inhibition, Ras and NF-kappa-B activities and tumor development. Does not suppress tumor development; when associated with A-728." evidence="9 16 17 19">
<original>R</original>
<variation>L</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits phosphorylation and TNF-alpha-induced MAP3K5 dephosphorylation. Reduces interaction with 14-3-3 proteins, AKT1, a regulatory p85 subunit, MAP3K5, RIPK1, TRAF2 and TNF-alpha-induced MAP3K5-JNK signaling and apoptosis. Reduces RAS activity. Does not reduce GSK3B-induced beta catenin-mediated transcription activity. Does not reduce NF-kappa-B activity, cell invasion, epithelial-to-mesenchymal transition (EMT) and tumor development. Does not suppress tumor development; when associated with R-413." evidence="13 14 16 19">
<original>S</original>
<variation>A</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with a regulatory p85 subunit of the PI3K complex. Inhibits MAP3K5 active form increase, AKT1 active form decrease, PI3K-p85 complex activity inhibition and TNF-induced apoptosis." evidence="16">
<original>PPPPPPPPPP</original>
<variation>AAAAAAAAAA</variation>
<location>
<begin position="920"/>
<end position="929"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not reduce interaction with 14-3-3 proteins." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="935"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAM00371." ref="1" evidence="26">
<original>I</original>
<variation>T</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAM00371." ref="1" evidence="26">
<original>P</original>
<variation>S</variation>
<location>
<position position="921"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAM00371." ref="1" evidence="26">
<original>QQ</original>
<variation>HE</variation>
<location>
<begin position="1091"/>
<end position="1092"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00167"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11944990"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12813029"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14978793"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15310755"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15701637"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389591"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18292600"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19033661"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19903888"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19948740"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20080667"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20154697"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700930"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22696229"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11214970"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11944990"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14978793"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20154697"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22696229"/>
</source>
</evidence>
<sequence length="1189" mass="131625" checksum="7494FF05AACF3320" modified="2006-10-17" version="2">MSAGGSARKSTGRSSYYYRLLRRPRLQRQRSRSRSRTRPARESPQERPGSRRSLPGSLSEKSPSMEPSAATPFRVTGFLSRRLKGSIKRTKSQPKLDRNHSFRHILPGFRSAAAAAADNERSHLMPRLKESRSHESLLSPSSAVEALDLSMEEEVVIKPVHSSILGQDYCFEVTTSSGSKCFSCRSAAERDKWMENLRRAVHPNKDNSRRVEHILKLWVIEAKDLPAKKKYLCELCLDDVLYARTTGKLKTDNVFWGEHFEFHNLPPLRTVTVHLYRETDKKKKKERNSYLGLVSLPAASVAGRQFVEKWYPVVTPNPKGGKGPGPMIRIKARYQTITILPMEMYKEFAEHITNHYLGLCAALEPILSAKTKEEMASALVHILQSTGKVKDFLTDLMMSEVDRCGDNEHLIFRENTLATKAIEEYLKLVGQKYLQDALGEFIKALYESDENCEVDPSKCSAADLPEHQGNLKMCCELAFCKIINSYCVFPRELKEVFASWRQECSSRGRPDISERLISASLFLRFLCPAIMSPSLFNLLQEYPDDRTARTLTLIAKVTQNLANFAKFGSKEEYMSFMNQFLEHEWTNMQRFLLEISNPETLSNTAGFEGYIDLGRELSSLHSLLWEAVSQLEQSIVSKLGPLPRILRDVHTALSTPGSGQLPGTNDLASTPGSGSSSISAGLQKMVIENDLSGLIDFTRLPSPTPENKDLFFVTRSSGVQPSPARSSSYSEANEPDLQMANGGKSLSMVDLQDARTLDGEAGSPAGPDVLPTDGQAAAAQLVAGWPARATPVNLAGLATVRRAGQTPTTPGTSEGAPGRPQLLAPLSFQNPVYQMAAGLPLSPRGLGDSGSEGHSSLSSHSNSEELAAAAKLGSFSTAAEELARRPGELARRQMSLTEKGGQPTVPRQNSAGPQRRIDQPPPPPPPPPPAPRGRTPPNLLSTLQYPRPSSGTLASASPDWVGPSTRLRQQSSSSKGDSPELKPRAVHKQGPSPVSPNALDRTAAWLLTMNAQLLEDEGLGPDPPHRDRLRSKDELSQAEKDLAVLQDKLRISTKKLEEYETLFKCQEETTQKLVLEYQARLEEGEERLRRQQEDKDIQMKGIISRLMSVEEELKKDHAEMQAAVDSKQKIIDAQEKRIASLDAANARLMSALTQLKERYSMQARNGISPTNPTKLQITENGEFRNSSNC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

